• Home
  • NEW DAY MEDICINE
  • 4 (78) 2025
  • 180 -4 (78) 2025 - Bobomuratov T.A., Bakirova M.A. - LOBARATOR ANALYSIS OF COAGULOPATHIES IN CHILDREN WITH POST-COVID SYNDROME

180 -4 (78) 2025 - Bobomuratov T.A., Bakirova M.A. - LOBARATOR ANALYSIS OF COAGULOPATHIES IN CHILDREN WITH POST-COVID SYNDROME

LOBARATOR ANALYSIS OF COAGULOPATHIES IN CHILDREN WITH POST-COVID SYNDROME

Bobomuratov T.A. - Tashkent Medical Academy

Bakirova M.A. - Tashkent Medical Academy

Resume

In children with severe forms of COVID-19, the blood coagulation system is prone to hypercoagulation, characterized by an increase in the concentration of fibrinogen and d-dimer. These changes lead to thrombosis of large blood vessels. In the course of our study, the state of the blood coagulation system during the recovery period of children of different ages infected with coronavirus was assessed and the causes of its occurrence were considered

Keywords: coagulopathies, children, inflammatory markers, Covid-19

First page

1008

Last page

1011

For citation:Bobomuratov T.A., Bakirova M.A. - LOBARATOR ANALYSIS OF COAGULOPATHIES IN CHILDREN WITH POST-COVID SYNDROME//New Day in Medicine 4(78)2025 1008-1011 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

  1. Xu S. W., Ilyas I., Weng J. P. Endothelial dysfunction in COVID-19: an overview of evidence,biomarkers, mechanisms and potential therapies.
  2. Acta Pharmacol Sin. 2022;17:1–15. doi:10.1038/s41401-022-00998-0
  3. Игнатенко Г. А., Налетов С. В., НалетоваЕ. Н., Сердюк Е. Б., Алесинский М. М., Налётова О.С.,Дисфункция эндотелия убольных гипертонической болезнью, перенесших COVID-19. Архив клинической и экспериментальной медицины. 2022;31(2): 127-131.
  4. Jing H., Wu X., Xiang M., Liu L., Novakovic V. A., Shi J. Pathophysiological mechanisms of thrombosis in acute and long COVID-19.Front Immunol. 2022;13:992384. doi:10.3389/fimmu.2022.992384.
  5. Mehrabi F., Farshbafnadi M., RezaeiN. Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis. Clin Appl Thromb.
  6. Kollias A., Kyriakoulis K. G., Dimakakos E., Poulakou G., Stergiou G. S., Syrigos K.Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020;189(5):846-847.doi:10. 1111/ bjh. 16727.
  7. Giannis D., Ziogas I. A., Gianni P.Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. doi: 10.1016/j.jcv.2020.104362.
  8. T.A. Bobomuratov, M.A. Bakirova “Bolalarda koronavirus infeksiyasidan so'ng tiklanish davrida gemostaz tizimining holati”-Вестник ТМА.2024
  9. Бобомуратов Т.А., Бакирова М.А., Маллаев Ш.Ш., Хошимов А.А Болаларда янги коронавирус инфекциясидан кейинги тикланиш даври ҳусусиятлари, Тошкент Тиббиёт академияси ахборотномаси, 2024, стр 37-39.

    file

    download